« Back
Home /
Secukinumab

Secukinumab

Item no.	DCC-A019-10mg
Manufacturer	DCChemicals
CASRN	1229022-83-6
Amount	10 mg
Quantity options	100 mg 10 mg 25 mg
Category	Oncology By Cell Type Hematology Leukemia Reagents & Chemicals Molecules By Organ Bladder Cancer
Type	Chemicals
Specific against	other
Smiles	DC Chemicals
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	</td></tr><tr><th>MW</th><td colspan="7">Therapeutic Antibodies
Similar products	875356-43-7
Available
Manufacturer - Applications	Secukinumab is a fully human immunoglobulin G1-kappa monoclonal antibody that directly inhibits interleukin (IL)-17A, has been shown to have robust efficacy in the treatment of moderate-to-severe psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing
Manufacturer - Category	Therapeutic Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10 mg

available

Delivery expected until 8/21/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer